Clene Inc (CLNN)
0.3772
-0.01
(-2.18%)
USD |
NASDAQ |
May 17, 16:00
0.3772
0.00 (0.00%)
After-Hours: 18:05
Clene Profit Margin (Quarterly): -15.18K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -15.18K% |
| December 31, 2023 | -5.98K% |
| September 30, 2023 | -2.24K% |
| June 30, 2023 | -9.35K% |
| March 31, 2023 | -11.00K% |
| December 31, 2022 | -450.4% |
| September 30, 2022 | -6.31K% |
| June 30, 2022 | -12.95K% |
| March 31, 2022 | -44.51K% |
| Date | Value |
|---|---|
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | -1.67K% |
| March 31, 2021 | -18.66K% |
| December 31, 2020 | |
| September 30, 2020 | -10.51K% |
| June 30, 2020 | -64.66K% |
| March 31, 2020 | -5.63K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-64.66K%
Minimum
Jun 2020
-450.4%
Maximum
Dec 2022
-14.94K%
Average
-9.93K%
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -122.2% |
| Protalix BioTherapeutics Inc | -122.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -413.9% |
| Return on Assets | -91.90% |
| Return on Invested Capital | -127.7% |
| Gross Profit Margin (Quarterly) | 78.08% |
| Operating Margin (Quarterly) | -11.91K% |
| Return on Net Operating Assets | -276.4% |